Quotient Sciences Announces Multimillion-Pound Investment in Drug Substance Manufacturing FacilityRead article
This presentation, delivered by Nikki Whitfield VP, CDMO Services, at the Drug Delivery & Formulation Summit 2019 (DDF) in Berlin, explains how to quickly develop first-in-human (FIH) dosage forms and bridge to drug products for proof-of-concept (POC).
Nikki possesses 25 years’ experience in the pharmaceutical industry and has previously held technical leadership positions in Quadrant Healthcare, Quadrant Drug Delivery and Elan where she was responsible for the development, transfer and scale up of both early phase and late phase spray-dried inhaled and topical products intended for both European and U.S. markets. In her previous position as a Project Director at Vectura, she led the early phase product development for two inhaled, orphan indication products and the late stage development for a novel sterile topical product. Nikki’s responsibilities at Quotient Sciences involve building the global formulation and manufacturing services business.